1. Home
  2. OMF vs BIO Comparison

OMF vs BIO Comparison

Compare OMF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

HOLD

Current Price

$54.58

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$284.99

Market Cap

7.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMF
BIO
Founded
1920
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
7.2B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
OMF
BIO
Price
$54.58
$284.99
Analyst Decision
Buy
Strong Buy
Analyst Count
12
4
Target Price
$69.17
$358.50
AVG Volume (30 Days)
1.6M
294.4K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
7.65%
N/A
EPS Growth
54.72
N/A
EPS
6.56
N/A
Revenue
N/A
N/A
Revenue This Year
$71.78
$2.31
Revenue Next Year
$6.89
$3.10
P/E Ratio
$8.37
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$38.00
$211.43
52 Week High
$71.93
$343.12

Technical Indicators

Market Signals
Indicator
OMF
BIO
Relative Strength Index (RSI) 33.90 50.13
Support Level $51.93 $266.71
Resistance Level $61.14 $290.01
Average True Range (ATR) 1.88 9.11
MACD -0.02 2.04
Stochastic Oscillator 18.21 75.36

Price Performance

Historical Comparison
OMF
BIO

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: